Posttranscriptional modulation of the human tissue-nonspecific alkaline phosphatase gene expression by 1,25-dihydroxyvitamin D3 in MG-63 osteoblastic osteosarcoma cells

Nutrition Research

Volumn 26, Issue 5, 2006, Pages 227-234

  Orimo, Hideo ^a   Shimada, Takashi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

1,25 Dihydroxyvitamin D3; MG 63 osteoblastic osteosarcoma cells; mRNA stability; Tissue nonspecific alkaline phosphatase; Vitamin D response element

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; LUCIFERASE; MESSENGER RNA; VITAMIN D;

ARTICLE; CANCER CELL CULTURE; CELL CULTURE; DNA RESPONSIVE ELEMENT; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 33746227674     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2006.05.004     Document Type: Article

References (49)

1. Harris H. The human alkaline phosphatases: what we know and what we don't know. Clin Chim Acta 186 (1989) 133-150
2. Whyte M.P. Hypophosphatasia: nature's window on alkaline phosphatase function in man. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of bone biology. 2nd ed vol. 2 (2002), Academic Press, San Diego 1229-1248
3. Weiss M.J., Ray K., Henthorn P.S., Lamb B., Kadesch T., and Harris H. Structure of the human liver/bone/kidney alkaline phosphatase gene. J Biol Chem 263 (1988) 12002-12010
4. Kiledjian M., and Kadesch T. Analysis of the human liver/bone/kidney alkaline phosphatase promoter in vivo and in vitro. Nucleic Acids Res 18 (1990) 957-961
5. Yusa N., Watanabe K., Yoshida S., Shirafuji N., Shimomura S., Tani K., et al. Transcription factor Sp3 activates the liver/bone/kidney-type alkaline phosphatase promoter in hematopoietic cells. J Leukoc Biol 68 (2000) 772-777
6. Orimo H., and Shimada T. Regulation of the human tissue-nonspecific alkaline phosphatase gene expression by all-trans retinoic acid in SaOS-2 osteosarcoma cell line. Bone 36 (2005) 866-876
7. Hui M., and Tenenbaum H.C. New face of an old enzyme: alkaline phosphatase may contribute to human tissue aging by inducing tissue hardening and calcification. Anat Rec 253 (1998) 91-94
8. Anderson H.C., Sipe J.B., Hessle L., Dhamyamraju R., Atti E., Camacho N.P., et al. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 164 (2004) 841-847
9. Orimo H., and Shimada T. Effects of phosphates on the expression of tissue-nonspecific alkaline phosphatase gene and phosphate-regulating genes in short-term cultures of human osteosarcoma cell lines. Mol Cell Biochem 282 (2006) 101-108
10. Fedde K.N., Blair L., Silverstein J., Coburn S.P., Ryan L.M., Weinstein R.S., et al. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14 (1999) 2015-2026
11. Weiss M.J., Cole D.E., Ray K., Whyte M.P., Lafferty M.A., Mulivor R.A., et al. A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc Natl Acad Sci U S A 85 (1988) 7666-7669
12. Henthorn P.S., Raducha M., Fedde K.N., Lafferty M.A., and Whyte M.P. Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proc Natl Acad Sci U S A 89 (1992) 9924-9928
13. Orimo H., Hayashi Z., Watanabe A., Hirayama T., Hirayama T., and Shimada T. Novel missense and frameshift mutations in the tissue-nonspecific alkaline phosphatase gene in a Japanese patient with hypophosphatasia. Hum Mol Genet 3 (1994) 1683-1684
14. Orimo H., Goseki-Sone M., Sato S., and Shimada T. Detection of deletion 1154-1156 hypophosphatasia mutation using TNSALP exon amplification. Genomics 42 (1997) 364-366
15. Mornet E. Hypophosphatasia: the mutations in the tissue-nonspecific alkaline phosphatase gene. Hum Mutat 15 (2000) 309-315
16. Orimo H., Girschick H.J., Goseki-Sone M., Ito M., Oda K., and Shimada T. Mutational analysis and functional correlation with phenotype in German patients with childhood-type hypophosphatasia. J Bone Miner Res 16 (2001) 2313-2319
17. Goseki-Sone M., Sogabe N., Fukushi-Irie M., Mizoi L., Orimo H., Suzuki T., et al. Functional analysis of the single nucleotide polymorphism (781T>C) in the tissue-nonspecific alkaline phosphatase gene associated with BMD. J Bone Miner Res 20 (2005) 773-782
18. 3: nuclear receptor structure and ligand specificities for genomic and rapid biological responses. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of bone biology. 2nd ed vol. 1 (2002), Academic Press, San Diego 545-571
19. Weston A.D., Hoffman L.M., and Underhill T.M. Revisiting the role of retinoid signaling in skeletal development. Birth Defects Res (Part C) 69 (2003) 156-173
20. Lin R., and White J.H. The pleiotropic actions of vitamin D. Bioessays 26 (2003) 21-28
21. 3 receptor-retinoid X receptor heterodimer-mediated transcription. Mol Cell Biol 15 (1995) 1154-1161
22. Drocourt L., Ourlin J.-C., Pascussi J.-M., Maurel P., and Vilarem M.-J. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 277 (2002) 25125-25132
23. 3 receptor: a network of coactivator interactions. Gene 246 (2000) 9-21
24. 3 stimulates both alkaline phosphatase gene transcription and mRNA stability in human bone cells. Arch Biochem Biophys 291 (1991) 316-325
25. 3 on differentiation of a human osteosarcoma (MG-63). J Biol Chem 267 (1992) 8943-8949
26. 3 and transforming growth factor-β act synergistically to override extinction of liver/bone/kidney alkaline phosphatase in osteosarcoma hybrid cells. Exp Cell Res 226 (1996) 67-74
27. Jeng Y.-J., Watson C.S., and Thomas M.L. Identification of vitamin D-stimulated alkaline phosphatase in IEC-6 cells, a rat small intestine crypt cell line. Exp Cell Res 212 (1994) 338-343
28. Gill R.K., and Bell N.H. Steroid receptor co-activator-1 mediates 1,25-dihydroxyvitamin D3-stimulated alkaline phosphatase in human osteosarcoma cells. Calcif Tissue Int 66 (2000) 370-374
29. San Miguel S.M., Goseki-Sone M., Sugiyama E., Watanabe H., Yanagishita M., and Ishikawa I. The effects of retinoic acid on alkaline phosphatase activity and tissue-non-specific alkaline phosphatase gene expression in human periodontal ligament cells and gingival fibroblasts. J Periodontal Res 33 (1998) 428-433
30. Cross H.S., Bareis P., Hofer H., Bischof M.G., Bajna E., Kriwanek S., et al. 25-Hydroxyvitamin D3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66 (2001) 287-292
31. Szabova L., Macejova D., Dvorcakova M., Mostbock S., Blazickova S., Zorad S., et al. Expression of nuclear retinoic acid receptor in peripheral blood mononuclear cells (PBMC) of healthy subjects. Life Sci 72 (2003) 831-836
32. 3. Proc Natl Acad Sci U S A 86 (1989) 4455-4459
33. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11 (1983) 1475-1489
34. Nakajima E., Ikejima M., Watanabe A., and Shimada T. Identification of the protein components of mismatch binding complexes in human cells using a gel-shift assay. FEBS Lett 453 (1999) 85-89
35. 3 in human osteosarcoma cells. J Biol Chem 263 (1988) 18938-18945
36. 3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc Natl Acad Sci U S A 87 (1990) 9995-9999
37. 3 or TGF-β1. Exp Cell Res 213 (1994) 433-437
38. Matsuura S., Kishi F., and Kajii T. Characterization of a 5′-flanking region of the human liver/bone/kidney alkaline phosphatase gene: two kinds of mRNA from single gene. Biochem Biophys Res Commun 168 (1990) 993-1000
39. 3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line. J Cell Physiol 123 (1985) 401-409
40. Stinson R.A., Thacker J.D., and Lin C.C. Expression and nature of the alkaline phosphatase gene in cultured osteosarcoma cells. Clin Chim Acta 221 (1993) 105-114
41. McQuillan D.J., Richardson M.D., and Bateman J.F. Matrix deposition by a calcifying human osteogenic sarcoma cell line (SAOS-2). Bone 16 (1995) 415-426
42. 3. Proc Natl Acad Sci U S A 89 (1992) 8097-8101
43. Mackey S.L., Heymont J.L., Kronenberg H.M., and Demay M.B. Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid X receptor. Mol Endocrinol 10 (1996) 298-305
44. Nishishita T., Okazaki T., Ishikawa T., Igarashi T., Hata K., Ogata E., et al. A negative vitamin D response DNA element in the human parathyroid hormone-related peptide gene binds to vitamin D receptor along with Ku antigen to mediate negative gene regulation by vitamin D. J Biol Chem 273 (1998) 10901-10907
45. Mahonen A., and Mäenpää P.H. Steroid hormone modulation of vitamin D receptor levels in human MG-63 osteosarcoma cells. Biochem Biophys Res Commun 205 (1994) 1179-1186
46. 3 in HL-60 cells. Calcif Tissue Int 61 (1997) 205-209
47. 3 upregulates natriuretic peptide receptor-C expression in mouse osteoblasts. Am J Physiol 275 (1998) E965-E973
48. Gledenning P., Ratajczak T., Dick I.M., and Prince R.L. Calcitriol upregulates expression and activity of the 1b isoform of the plasma membrane calcium pump in immortalized distal kidney tubular cells. Arch Biochem Biophys 380 (2000) 126-132
49. González E.A., Disthabanchong S., Kowalewski R., and Martin K.J. Mechanisms of the regulation of EGF receptor gene expression by calcitriol and parathyroid hormone in UMR 106-01 cells. Kidney Int 61 (2002) 1627-1634